Potential drug targets for multiple sclerosis identified through Mendelian randomization analysis
Open accessThe DOI matches its Crossref record; 54 of the 56 references it cites were found in a registry or an index.
Abstract
Multiple sclerosis is a complex autoimmune disease, and several therapies for multiple sclerosis have been developed and widely used. However, existing medications for multiple sclerosis were far from satisfactory due to their failure to suppress relapses and alleviate disease progression. Novel drug targets for multiple sclerosis prevention are still needed. We performed Mendelian randomization to explore potential drug targets for multiple sclerosis using summary statistics from the International Multiple Sclerosis Genetics Consortium (nCase = 47 429, nControl = 68 374) and further replicated in UK Biobank (nCase = 1356, nControl = 395 209) and FinnGen cohorts (nCase = 1326, nControl = 359 815). Genetic instruments for 734 plasma and 154 CSF proteins were obtained from recently published genome-wide association studies. The reverse causality detection using bidirectional Mendelian randomization analysis and Steiger filtering, Bayesian co-localization, and phenotype scanning that searched previously reported genetic variant–trait associations were implemented to consolidate the Mendelian randomization findings further. In addition, the protein–protein interaction network was performed to reveal potential associations among proteins and/or present multiple sclerosis medications. At Bonferroni significance (P < 5.63 × 10−5), Mendelian randomization analysis revealed six protein–multiple sclerosis pairs. In plasma, per standard deviation increase in FCRL3, TYMP and AHSG had a protective effect. Odds ratios for the proteins above were 0.83 (95% CI, 0.79–0.89), 0.59 (95% CI, 0.48–0.71) and 0.88 (95% CI, 0.83–0.94), respectively. In CSF, per 10-fold increase in MMEL1 (OR, 5.03; 95% CI, 3.42–7.41) increased the risk of multiple sclerosis, while SLAMF7 (OR, 0.42; 95% CI, 0.29–0.60) and CD5L (OR, 0.30; 95%CI, 0.18–0.52) decreased the risk. None of the six proteins had reverse causality. Bayesian co-localization suggested that FCRL3 [coloc.abf-posterior probability of hypothesis 4 (PPH4) = 0.889], TYMP (coloc.susie-PPH4 = 0.896), AHSG (coloc.abf-PPH4 = 0.957, coloc.susie-PPH4 = 0.973), MMEL1 (coloc.abf-PPH4 = 0.930) and SLAMF7 (coloc.abf-PPH4 = 0.947) shared the same variant with multiple sclerosis. FCRL3, TYMP and SLAMF7 interacted with target proteins of current multiple sclerosis medications. MMEL1 was replicated in both UK Biobank and FinnGen cohorts. Our integrative analysis suggested that genetically determined levels of circulating FCRL3, TYMP, AHSG, CSF MMEL1 and SLAMF7 had causal effects on multiple sclerosis risk. These findings suggested those five proteins might be promising drug targets for multiple sclerosis and warrant further clinical investigation, especially FCRL3 and SLAMF7.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MR uses genetic variants as instrumental variables, providing robust causal inference and offering insight into the biological pathways driving disease progression [16,17].”
From Identifying novel drug targets for calcific aortic valve disease through Mendelian randomization (2025) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Szklarczyk, D., Gable, A. L., Lyon, D., Junge, A., Wyder, S., Huerta-Cepas, J., Simonovic, M., Doncheva, N. T., Morris, J. H., Bork, P., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1131 · Cited by 17,749 · cited 1×
“28 In addition, we conducted MR by Wald ratio method and Bayesian co-localization by coloc.abf algorithm with prioritized proteins as both exposure and outcome.”
Sudlow, C., Gallacher, J., Allen, N., Beral, V., Burton, P., Danesh, J., Downey, P., Elliott, P., Green, J., Landray, M., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001779 · Cited by 12,728 · cited 7×
“Finally, using the GWAS data from the UK Biobank 13 and FinnGen 14 cohorts and plasma pQTL data from two newly published studies, 15,16 we replicated the analysis as an exter-nal validation to strengthen our conclusion.”
InfluentialDrugBank 5.0: a major update to the DrugBank database for 2018
Wishart, D. S., Feunang, Y. D., Guo, A. C., Lo, E. J., Marcu, A., Grant, J. R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1037 · Cited by 8,404 · cited 1×
“27 We also searched current medications targeting the identified potential causal proteins.”
Mendelian randomization: genetic anchors for causal inference in epidemiological studies
Davey Smith, G., & Hemani, G. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu328 · Cited by 4,677 · cited 1×
“23 Complete summary statistics for proteins were obtained from three previous studies.”
Giambartolomei, C., Vukcevic, D., Schadt, E. E., Franke, L., Hingorani, A. D., Wallace, C., & Plagnol, V. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004383 · Cited by 4,261 · cited 1×
“…for posterior probability, five proteins identified by MR (FCRL3, TYMP, AHSG, MMEL1 and SLAMF7) were likely to share the same variant of MS. 33 Four of the five identified proteins (FCRL3, TYMP, AHSG and MMEL1) were found to be associated with other traits via phenotype scanning, but none…”
Orienting the causal relationship between imprecisely measured traits using GWAS summary data.
Hemani, G., Tilling, K., & Davey Smith, G. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1007081 · Cited by 2,607 · cited 1×
“We also conducted Steiger filtering to ensure the directionality of the association between proteins and MS. 24 The results were considered statistically significant at P < 0.05.”
InfluentialGenomic atlas of the human plasma proteome
Sun, B. B., Maranville, J. C., Peters, J. E., Stacey, D., Staley, J. R., Blackshaw, J., Burgess, S., Jiang, T., Paige, E., Surendran, P., et al. (2018) · Nature · doi:10.1038/s41586-018-0175-2 · Cited by 2,268 · cited 2×
“12,16,18 The effect was estimated using MR-IVW, MR-Egger, weighted median, simple mode and weighted mode.”
PhenoScanner V2: an expanded tool for searching human genotype–phenotype associations
Kamat, M. A., Blackshaw, J. A., Young, R., Surendran, P., Burgess, S., Danesh, J., Butterworth, A. S., & Staley, J. R. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz469 · Cited by 2,155 · cited 1×
“Phenotype scanning was conducted via both ‘phe-noscanner’ 26 and looking up in the study of Ferkingstad et al .”
Dobson, R., & Giovannoni, G. (2019) · European Journal of Neurology · doi:10.1111/ene.13819 · Cited by 2,148
Guidelines for performing Mendelian randomization investigations
Burgess, S., Davey Smith, G., Davies, N. M., Dudbridge, F., Gill, D., Glymour, M. M., Hartwig, F. P., Holmes, M. V., Minelli, C., Relton, C. L., et al. (2019) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15555.1 · Cited by 1,834
Cited by
Items 201–281 of 281
Lipid Targets for Benign Colon Neoplasm through Mendelian Randomization AnalysisPreprint
Liao, Y., Xiao, C., Fahira, A., Zhang, Z., Hou, B., & Huang, Z. (2025) · Research Square · doi:10.21203/rs.3.rs-6608722/v1
Zhao, Y., Ruan, Q., Ning, J., Zhang, X., Qu, R., Zou, J., Liang, Y., Zhang, C., & Zhang, Y. (2026) · Journal of the Egyptian National Cancer Institute · doi:10.1186/s43046-026-00374-7
“With the rapid advancement of high-throughput proteomics techniques in plasma analysis, researchers have established a causal relationship between plasma proteins and various diseases, including multiple sclerosis, acne, and breast cancer, through MR analysis [12–14].”
Wang, Y., Yao, T., Lin, Y., & Wu, J. (2025) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s523231
“39,40 To enhance the clinical applicability of the GWAS findings, we conducted a series of sensitivity and druggability analyses.”
Zhang, Y., Wang, B., Chen, B., & Wan, Q. (2025) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188251343140
“29 All the statistical analyses were conducted via the TwoSampleMR package (version 0.5.6) and the coloc package within the R software environment (version 4.3.3).”
InfluentialZhao, Z., Cai, Y., Li, C., Du, C., & Zhang, S. (2025) · Research Square · doi:10.21203/rs.3.rs-6806548/v1
Zhou, E., Luo, S., Xiao, Y., Liu, B., & Xiao, X. (2025) · World Journal of Otorhinolaryngology - Head and Neck Surgery · doi:10.1002/wjo2.70038
“We analyzed all SNPs within a ± 500 ‐ kb range of cis ‐ pQTL and calculated the posterior probabilities for the five hypotheses (PPH0 – PPH4), with PPH4 > 0.8 considered as evidence for co-localisation [22].”
InfluentialLiu, X., Chen, J., Zhou, S., & Lin, J. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5343605
Self-citationShi, S., Liu, M., Gao, H., Liu, F., & Song, Y. (2025) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/cjgh/1716853
“Currently, MMELI is associated with PBC [33], rheumatoid arthritis [34], and multiple sclerosis [35, 36] Although re-searches do not provide direct evidence implicating the Canadian Journal of Gastroenterology and Hepatology association between MMEL1 and hypothyroidism, the involvement of MMEL1 in…”
Saba, A., Liu, R., Wang, S.-X., Shehzadi, K., Xu, W.-H., Xu, Y., Liang, J., & Yu, M. (2025) · ACS Omega · doi:10.1021/acsomega.5c03682
Self-citationMulti-omics and Mendelian randomization study explores potential therapeutic targets for meningiomas
Li, Y., Lin, L., Zhang, W., Wang, Y., Shen, H., & Guan, Y. (2025) · Discover Oncology · doi:10.1007/s12672-025-03318-0
“Moreover, MR has shown extraordinary value in proteomics and exploration of potential drug targets for diseases such as Alzheimer’s disease [21], multiple sclerosis [22], and other complex diseases.”
Zheng, L., Yin, Y., Wang, X., Wang, B., Cui, R., & Zhang, G. (2025) · Frontiers in Genetics · doi:10.3389/fgene.2025.1631446 · Cited by 1
“We then adopted the signi fi cant variation strategy, that is, after replacing the GWAS data source, we reperformed rigorous MR analysis using genome-wide signi fi cant SNPs as a genetic tool to verify the preliminary fi ndings (Lin et al., 2023).”
Li, C., Sun, A., Liu, Y.-K., Sun, R., Hao, A.-Y., Lan, Y., Cao, J., & Wang, Z. (2025) · Medicine · doi:10.1097/md.0000000000044608 · Cited by 1
“[40] In our MR research, GWAS data of PSC were resourced from the most extensive dataset: IPSCSG (2871 cases and 12,019 controls) and FinnGen R10 (1843 cases and 361,641 controls) (Table S1, Supplemental Digital Content, https://links.lww.com/MD/Q18).”
Zhang, Y., Teng, Z., Zhao, J., Tu, Y., Li, Q., & Fu, L. (2025) · Archives of Medical Science · doi:10.5114/aoms/208855
Zhu, W., Zhang, R., Qi, Y., Hu, C., 李建国, & Hu, B. (2025) · Research Square · doi:10.1101/2025.10.03.25337304
“…Steiger filtering method was used to examine the directionality of the results, ensuring their alignment with the hypothesized direction of effect (39 preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright…”
Yue, H., Tian, J., Yin, W., & Zhao, H. (2025) · International Journal of General Medicine · doi:10.2147/ijgm.s535716
A potential drug target in epilepsy and its role in other neurological disorders
Gao, S., Shen, Y., Shen, Y., Fang, X., Zhang, W., Wang, Y., Zhang, H.-P., Yang, S., & Liang, H. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04696-6
Wan, F. J., Shen, J., & Tang, J. (2025) · Medicine · doi:10.1097/md.0000000000045444
“[11] Proteome-wide MR has successfully prioritized drug targets for a range of diseases, including autoimmune, [12] neurological, [13] and oncologic conditions.”
Tan, H., Li, S., Yan, H., Li, F., Yao, Y., Li, Y., & Qian, F. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05439-7
Hu, X., Wei, X., Lan, D., & Guo, Z. (2025) · Medicine · doi:10.1097/md.0000000000045983
“[42] Additionally, CD109 influences the postoperative recurrence of recurrent CRSwNP. [34] The present study further confirms the potential of CD109 as a diagnostic marker for CRSwNP. Similar signaling pathways have been observed in tumor cells, where FLOT2 upregulates CD109 by stabilizing the…”
Xiao, L., Wang, Y., Xiong, Y., Zhuang, Z., Hu, C., & Xiao, Z. (2025) · Discover Oncology · doi:10.1007/s12672-025-04246-9 · Cited by 1
“Many researchers have also successfully identified disease-related drug targets based on MR analysis, including targets for conditions such as hypertension, IgA nephropathy, and multiple sclerosis [27–29].”
Ding, K., Zhangwang, J., Lei, M., & Xiong, C. (2024) · Figshare · doi:10.6084/m9.figshare.26687963
Wang, Q., Chen, S., Wang, G., Zhang, T., & Gao, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26734977
Zong, L., Liu, G., He, H., & Huang, D. (2024) · Figshare · doi:10.6084/m9.figshare.26722311
Ding, K., Zhangwang, J., Lei, M., & Xiong, C. (2024) · Figshare · doi:10.6084/m9.figshare.26687936
Sun, D., Wang, R., Du, Q., Zhang, Y., Chen, H., Shi, Z., Wang, X., & Zhou, H. (2024) · Figshare · doi:10.6084/m9.figshare.26670408
Zong, L., Liu, G., He, H., & Huang, D. (2024) · Figshare · doi:10.6084/m9.figshare.25853207
Ding, K., Zhangwang, J., Lei, M., & Xiong, C. (2024) · Figshare · doi:10.6084/m9.figshare.26687957
Ding, K., Zhangwang, J., Lei, M., & Xiong, C. (2024) · Figshare · doi:10.6084/m9.figshare.26687951
Zong, L., Liu, G., He, H., & Huang, D. (2024) · Figshare · doi:10.6084/m9.figshare.26722317
Zong, L., Liu, G., He, H., & Huang, D. (2024) · Figshare · doi:10.6084/m9.figshare.25853020
Ding, K., Zhangwang, J., Lei, M., & Xiong, C. (2024) · Figshare · doi:10.6084/m9.figshare.26687939
Ding, K., Zhangwang, J., Lei, M., & Xiong, C. (2024) · Figshare · doi:10.6084/m9.figshare.26687966
Wang, Q., Chen, S., Wang, G., Zhang, T., & Gao, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26734980
Ding, K., Zhangwang, J., Lei, M., & Xiong, C. (2024) · Figshare · doi:10.6084/m9.figshare.26687948
Zong, L., Liu, G., He, H., & Huang, D. (2024) · Figshare · doi:10.6084/m9.figshare.26722314
Wang, Q., Chen, S., Wang, G., Zhang, T., & Gao, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26054755
Ding, K., Zhangwang, J., Lei, M., & Xiong, C. (2024) · Figshare · doi:10.6084/m9.figshare.26687945
Ding, K., Zhangwang, J., Lei, M., & Xiong, C. (2024) · Figshare · doi:10.6084/m9.figshare.26687942
Ren, F., Jin, Q., Liu, T., Ren, X., & Zhan, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26618791
Wang, Q., Chen, S., Wang, G., Zhang, T., & Gao, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26054656
Ding, K., Zhangwang, J., Lei, M., & Xiong, C. (2024) · Figshare · doi:10.6084/m9.figshare.26687960
Wang, Q., Chen, S., Wang, G., Zhang, T., & Gao, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26734983
Ding, K., Zhangwang, J., Lei, M., & Xiong, C. (2024) · Figshare · doi:10.6084/m9.figshare.26687954
Mei, X., Li, B., Sun, L., Tian, Y., Li, Y., Wu, N., Li, D. G., Ren, H., Ge, M., & Wang, D. (2025) · Diabetic Medicine · doi:10.1111/dme.70176
“21 2.1 .6 | Eliminate confounding factors Beyond utilizing independent exposure-outcome GWAS datasets to avoid sample overlap, we performed confounder scanning for significant IVs to satisfy the second core MR assumption-independence from confounding factors.”
InfluentialYi, P., Ying, Q., Zhang, H., Yang, C., Zhu, Y., Xia, Z., Xu, F., & Mi, J. (2025) · Global Medical Genetics · doi:10.1016/j.gmg.2025.100092
Chen, S. R. W., Li, X., & Xie, R. (2026) · International Journal of COPD · doi:10.2147/copd.s572586 · Cited by 1
“22”
Zhang, M., Dai, X., Huang, B., Zheng, S., Liu, H., Zhao, L., Liu, P., & Gao, Y. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.109544 · Cited by 1
Zhang, Z., Tu, M., Yuan, N., Qian, W., Wang, G., Lin, M., Xie, J., Liang, L., Guo, J., Zhang, B., et al. (2026) · Journal of Visualized Experiments · doi:10.3791/69569
Chen, Z., Tang, Y., Li, S., Pan, L., Wu, J., Liu, J., Ma, H., Wang, B., & Xie, K. (2026) · BMC Medicine · doi:10.1186/s12916-026-04691-5
“To minimize pleiot-ropy and LD bias, QTL-derived IVs were further refined by excluding variants within the major histocompatibility complex region and retaining only cis-variants located within ± 1 MB of the target gene [34].”
Xi, J., Wang, S., Chen, J., Law, J. C. S., Wang, J., Lee, G. H., Fan, Z., Lv, G., & Chen, Y. (2026) · PLoS ONE · doi:10.1371/journal.pone.0340166
Update on pharmacogenomic approaches in the treatment of autism spectrum disorders
Thapa, K., Khan, H., Kanojia, N., Kumar, J., Singh, T., & Grewal, A. K. (2026) · Psychopharmacology · doi:10.1007/s00213-026-07020-z · Cited by 1
“Colocalization approaches investigates the overlap of genetic signals between two traits, such as gene expression and disease susceptibility, to determine shared loci and reveal potential causal links (Lin et al. 2023).”
Ji, T., Lv, Y., & Gu, J. (2026) · International Journal of COPD · doi:10.2147/copd.s561510
“14,15 As an extension of traditional MR, the summary data-based MR (SMR) method was devised to strengthen the ability to investigate genetic associations between molecular phenotypes and various diseases.”
Chen, L., Sun, H., Fang, M.-J., Cheng, N., & Xu, Y. (2026) · International Journal of Surgery · doi:10.1097/js9.0000000000005020
“This method operates under the premise that a valid instrumental variable must account for a greater proportion of variance in the exposure (protein levels) than in the outcome (EOAD/LOAD) [ 27 ] .”
Self-citationYou, R., Liu, Z.-Y., Li, M.-S., Li, Y., Wang, X., Zhou, X.-J., & Zhang, H. (2026) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.0000001022 · Cited by 1
“15,16 Previous study performed the MR-pheWAS and found that nine proteins are casually associated with the IgA nephropathy in European and two proteins in Asian population.”
Zhao, Y., Lei, J., Wang, Z., Yang, S., Zhao, Z., Xie, Y., Ran, J., & Zang, G. (2026) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00989
Zhou, D.-M., Zheng, K.-C., Zhang, S., & Zheng, B.-B. (2026) · Biochemistry Research International · doi:10.1155/bri/3548900
“To uphold the fundamental assumption that GIVs should exclusively infuence the outcome through exposure, we applied Steiger fltering to confrm that each SNP has a signifcant primary association with the exposure rather than the outcome [16].”
Gut microbiota composition causally linked to Alzheimer’s disease: Mendelian randomization evidence
Zhou, Y., Tang, H., Sun, Y., Li, C., Zhao, Y., & Chen, L. (2025) · Aging Research · doi:10.26599/agr.2025.9340071
Qin, Q., Wang, Y., Zhang, L., Li, Z., Wang, J., & Yu, X. (2026) · Journal of Inflammation Research · doi:10.2147/jir.s581720 · Cited by 1
“27”
Zhang, J. I.-X., Lu, S., Liang, G., Wang, R., Zhou, H., Na, N., Liu, M., & Zhong, Z. (2026) · Medicine · doi:10.1097/md.0000000000048751
“[23] For genes with 2 or more available genetic IVs, the inverse variance-weighted (IVW) method was employed to combine causal estimates from multiple IVs, [24] providing a more comprehensive and accurate assessment of potential causal links between the DEGs and the risk of IgAN and CKD. MR-Egger…”
Genetic Identification of Potential Drug Targets for Dental Caries: A Mendelian Randomization Study
毕俊蕾, Liu, A., Zhang, N., Chen, Y., Liu, C., Zhu, Y., Wen, H., & Ma, C. (2026) · Health Science Reports · doi:10.1002/hsr2.72546
“Compared to observational studies, MR avoids the influence of confounding factors [9].”
Unveiling novel drug targets for atherosclerosis: A Mendelian randomization analysis
Du, W., Li, D., Li, N., Zhang, W., Wang, J., Wang, T., & Zeng, Y. (2026) · Medicine · doi:10.1097/md.0000000000048919
“[12,13] While applications in fields such as cancer and coronary heart disease have been established, MR studies that combine GWAS data with protein quantitative trait loci (pQTL) information specifically for AS have been scarce.”
Genetic‐Proteomic Integration Identifies Predictive Plasma Proteins for Multiple Sclerosis
Ding, Y., Hamitouche, D., Thebault, S., Kearns, P., Abdelhak, A., & Harroud, A. (2026) · Annals of Neurology · doi:10.1002/ana.78256
Jiang, Y., Xiao, J., Kockum, I. S., Stridh, P., Liu, Q., Olsson, T. P., Alfredsson, L. S., & Jiang, X. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03895-z
Chen, X. T., Chen, S., Zhao, S., Li, Y., Chang, J., Shi, S., Xu, D., Li, L. J., & Chen, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1754277
“Bidirectional MR analyses indicated no evidence of reverse causality for the proteins identi fi ed, a conclusion further supported by Steiger fi ltering (40).”
Yu, Z., Mao, S., Song, Y., Meng, X., Yu, J., Zong, Z., Gao, T., & Chen, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1861490
Huang, J., Chen, Z., Lin, M., Xu, B., Liu, Q., Li, Z., Gao, J., Yi, G., & Fu, M. (2026) · Medicine Advances · doi:10.1002/med4.70072
Mapping Causal Biology: Mendelian Randomization in the Era of Big Data
Shen, X., Qu, C., Wang, Z., Zhou, J., LIU, H. J., Li, Y., Liu, B. A., Zhang, H., Zhang, N., Zhang, J., et al. (2026) · Med Research · doi:10.1002/mdr2.70074 · Cited by 1
Self-citationWen, L., Liu, Y., Zhang, K., Mao, A., Geng, L., Yu, F., Feng, L., & Kan, H. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146178
“6.3) [41].”
InfluentialPotential role of Akkermansia massiliensis in multiple sclerosis protection by the FcRL3 gene
Orrù, V., Marongiu, M., Cocco, E. E., & Żołędziewska, M. (2026) · Genes and Immunity · doi:10.1038/s41435-026-00404-3
Zhao, Z., Cai, Y., Li, C. J., Du, C., & Zhang, S. (2026) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.71206
Zhang, Z., Mo, Y., Wu, S., Li, T., Wu, Y., Li, Y., Hao, X., & Liu, C. (2026) · Medicine · doi:10.1097/md.0000000000049938 · Cited by 1
“[32] Between-instrument heterogeneity was assessed using Cochran Q statistic, and directional pleiotropy using the MR-Egger intercept.”
Bestatin inhibits the development of cutaneous melanoma by inhibiting the expression of LTA4H
Luo, P., Yang, M., Su, Y., Wen, P., & Lu, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1901844
Li, Y., Yi, Z., Dong, X., Sun, R., Gao, L., Zheng, Y., & Liu, H. (2026) · Journal of Global Health · doi:10.7189/jogh.16.04268
“Default prior probabilities were applied (p 1 = p 2 = 1E – 4, p 12 = 1E – 5) [ 66 , 67 ].”
Chen, L., Hsieh, H., Cheng, N., & Xu, Y. (2026) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2026.112098
Self-citationChen, L., Fang, M.-J., Cheng, N., & Xu, Y. (2026) · Genes · doi:10.3390/genes17091067
“We applied Steiger filtering methodology to test and verify the direction of associations between identified proteins and dystonia [18].”
Self-citationGenetic evidence for CTSH as a potential therapeutic target in sepsis
Du, Y., Zhou, L., Huang, B., Feng, L., Jin, Q., & Lin, G. (2026) · Medicine · doi:10.1097/md.0000000000050487
“[20] This method calculates the posterior probabilities of 5 hypotheses: H0 (neither trait associated), H1 (only the first trait associated), H2 (only the second trait associated), H3 (both traits associated but with different variants), and H4 (both traits associated with the same variant).”
Jiang, S., Xiao, D., Chen, Y., Kuang, Y., Xian-Gan, C. H. E. N., Li, Z., Zhang, C., & Li, J. (2026) · Research Square · doi:10.21203/rs.3.rs-10879351/v1
Pan, L., Yang, X., Hao, Q., Xie, K., & Ma, H. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1745748
“To reduce potential pleiotropy bias at the gene level, protein quantitative trait loci (pQTL) IVs for plasma proteins were limited to loci within 1MB upstream and downstream of the gene, excluding SNPs in the major histocompatibility complex region (Chr6, 26-34MB) (13).”
Mendelian randomisation identifies proteins with effects on multiple sclerosis and related traits
Boyton, M., Khandaker, G. M., Walker, V. M., & Gaunt, T. R. (2026) · Wellcome Open Research · doi:10.12688/wellcomeopenres.27571.1
Li, T., Huang, C., Deng, H., You, Y., Jiang, Y., Wang, Z., Wang, Q., Chen, K., & Chen, D. (2026) · Functional & Integrative Genomics · doi:10.1007/s10142-026-02083-9
“Additionally, we used Steiger filtering (Lin et al. 2023).”
Secreted factors mediate the crosstalk between liver fibrosis, atherosclerosis, and bone metabolism
Hu, L., Li, H., Zhang, W., Chen, S., Cai, Z., Chen, M., Liang, W., Bai, X., & Liu, X. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.154780
Metadata
- Authors
- Lin, J., Zhou, J., & Xu, Y.
- Affiliations
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Corresponding author
- Xu, Yan
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2023-03-02
- Volume
- 146
- Issue
- 8
- Pages
- 3364-3372
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC10393411
- OpenAlex
- W4323035146
- Cited by
- 271
- References
- 56
- Citations by year
- 2026: 43 · 2025: 87 · 2024: 120 · 2023: 21
- FWCI
- 55.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Brain (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Peking Union Medical College Deposition Research Fund (ZC201904188)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Mapping and Diversity in Plants and Animals
- Keywords
- multiple sclerosis, therapeutic target, plasma proteins, cerebrospinal fluid protein, FCRL3, SLAMF7, CD5L, fetuin-A, thymidine phosphorylase, reverse causality, protein-protein interaction network, autoimmune disease, genetic risk factors, disease progression, relapse prevention, neuroinflammation, neurodegeneration
- MeSH terms
- Bayes Theorem, Humans, Multiple Sclerosis, Phenotype, Polymorphism, Single Nucleotide, Genome-Wide Association Study, Mendelian Randomization Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.